Editas Medicine, Inc. - 10-Q filing on 2016-05-13

Fair Value Measurements (Tables)

3 Months Ended

Mar. 31, 2016

Assets measured at fair value on a recurring basis as of March 31, 2016 were as follows (in thousands):


			Quoted Prices		Significant
			in Active		Other		Significant
			Markets for		Observable		Unobservable
	March 31,		Identical Assets		Inputs		Inputs
Assets	2016		(Level 1)		(Level 2)		(Level 3)
Cash and cash equivalents	$	229,204	$	229,204	$	—	$	—
Money market funds, included in other current assets		320		320		—		—
Money market funds, included in other non-current assets		1,619		1,619		—		—
Total	$	231,143	$	231,143	$	—	$	—

Assets and liabilities measured at fair value on a recurring basis as of December 31, 2015 were as follows (in thousands):


			Quoted Prices		Significant
			in Active		Other		Significant
			Markets for		Observable		Unobservable
	December 31,		Identical Assets		Inputs		Inputs
Assets	2015		(Level 1)		(Level 2)		(Level 3)
Cash and cash equivalents	$	143,180	$	143,180	$	—	$	—
Money market funds, included in other current assets		320		320		—		—
Total	$	143,500	$	143,500	$	—	$	—
Liabilities
Warrant liability	$	289	$	—	$	—	$	289

The following table presents activity in the preferred stock warrant during the three months ended March 31, 2016 (in thousands):


		Warrant
		Liability
Fair value at December 31, 2015	$	289
Increase in fair value recognized in other expense		87
Reclassification to additional paid-in capital in connection with IPO		(376)
Fair value at March 31, 2016	$	—